Header cover image

U.S. Pharma Industry Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies315
  • 7D1.6%
  • 3M10.7%
  • 1Y9.9%
  • YTD5.5%

Over the last 7 days, the Pharma industry has risen 1.6%, driven by gains from Merck of 3.1%. Meanwhile, Arvinas actually underperformed within the industry, shrinking 21% in the last week. In the last 12 months, the industry was up 9.9%. Looking forward, earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022US$1.7tUS$403.7bUS$70.7b16.9x24.7x4.3x
Wed, 26 Oct 2022US$1.7tUS$403.4bUS$72.1b13.5x22.9x4.1x
Fri, 23 Sep 2022US$1.6tUS$403.0bUS$71.3b12.9x22x3.9x
Sun, 21 Aug 2022US$1.7tUS$402.8bUS$70.1b15.3x23.7x4.1x
Tue, 19 Jul 2022US$1.7tUS$392.4bUS$65.1b22x26.1x4.3x
Thu, 16 Jun 2022US$1.6tUS$392.5bUS$64.7b20.6x24.3x4x
Sat, 14 May 2022US$1.6tUS$392.5bUS$64.4b20.4x25.3x4.1x
Mon, 11 Apr 2022US$1.7tUS$373.8bUS$60.7b22.4x28.5x4.6x
Wed, 09 Mar 2022US$1.6tUS$373.6bUS$60.3b19.5x25.7x4.2x
Fri, 04 Feb 2022US$1.6tUS$364.0bUS$40.7b21.6x39x4.4x
Sun, 02 Jan 2022US$1.7tUS$361.1bUS$37.8b22.9x44x4.6x
Tue, 30 Nov 2021US$1.5tUS$361.1bUS$38.1b22.6x40.6x4.3x
Thu, 28 Oct 2021US$1.5tUS$341.0bUS$24.7b20.2x61.6x4.5x
Sat, 25 Sep 2021US$1.5tUS$337.6bUS$25.8b22x58.3x4.5x
Mon, 23 Aug 2021US$1.6tUS$338.5bUS$25.8b19.5x63x4.8x
Sat, 10 Jul 2021US$1.5tUS$324.4bUS$20.4b23.4x73.2x4.6x
Fri, 02 Apr 2021US$1.4tUS$309.5bUS$16.9b18.8x83.5x4.5x
Mon, 04 Jan 2021US$1.4tUS$303.0bUS$18.3b18.8x75.1x4.5x
Thu, 08 Oct 2020US$1.3tUS$284.8bUS$25.5b20.6x50.2x4.5x
Wed, 01 Jul 2020US$1.2tUS$279.3bUS$31.3b25.8x39.3x4.4x
Sat, 04 Apr 2020US$1.1tUS$298.7bUS$33.5b19.2x33.7x3.8x
Tue, 07 Jan 2020US$1.3tUS$295.5bUS$32.2b20x40.3x4.4x
Price to Earnings Ratio

31.5x


Total Market Cap: US$1.2tTotal Earnings: US$38.6bTotal Revenue: US$295.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 45.1x202020212022
Current Industry PE
  • Investors are pessimistic on the American Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.7x which is lower than its 3-year average PE of 45.1x.
  • The industry is trading close to its 3-year average PS ratio of 4.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 22% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market1.26%
Healthcare1.63%
Pharma1.59%
Pharma1.59%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MRK MerckUS$107.503.1%
+US$8.3b
35.8%PE17.8x
PFE PfizerUS$49.212.0%
+US$5.5b
-8.9%PE9.2x
BMY Bristol-Myers SquibbUS$79.242.3%
+US$4.0b
40.2%PE26.3x
LLY Eli LillyUS$365.251.0%
+US$3.4b
40.3%PE57.5x
JNJ Johnson & JohnsonUS$177.240.6%
+US$2.7b
11.3%PE24.2x
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

JAZZ

US$153.00

Jazz Pharmaceuticals

7D

4.0%

1Y

23.3%

BHC

US$6.90

Bausch Health Companies

7D

-8.9%

1Y

-72.7%

ARVN

US$40.34

Arvinas

7D

-21.4%

1Y

-48.5%

PFE

US$49.21

Pfizer

7D

2.0%

1Y

-8.9%

ACRS

US$17.53

Aclaris Therapeutics

7D

-4.6%

1Y

38.9%

LGND

US$73.61

Ligand Pharmaceuticals

7D

-4.8%

1Y

-53.1%

SCLX

US$4.82

Scilex Holding

7D

-13.0%

1Y

-52.0%

NKTR

US$3.24

Nektar Therapeutics

7D

-7.2%

1Y

-71.1%

ELAN

US$12.57

Elanco Animal Health

7D

5.5%

1Y

-58.4%

CTLT

US$41.39

Catalent

7D

-3.8%

1Y

-68.7%

RETA

US$36.03

Reata Pharmaceuticals

7D

-5.0%

1Y

-55.7%

JNJ

US$177.24

Johnson & Johnson

7D

0.6%

1Y

11.3%